Skip to main content
OpenTrials

Clinical trial condition

Arteriosclerosis

Explore clinical trials studying Arteriosclerosis. Study availability and eligibility vary by location and protocol.

5,359 public trials 756 recruiting studies
Refine in advanced search Browse all conditions

Arteriosclerosis trial results

Completed

A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)

NCT00824434

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +6 more
Locations
  • St. Vincent's Hospital - Sydney Darlinghurst, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Monash Medical Centre Clayton, Victoria, Australia
  • St. Vincent Hospital (Melbourne) Fitzroy, Victoria, Australia
View all 17 locations
View Trial Details
Completed

Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease

NCT01107925

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cincinnati, Ohio, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dublin, Ireland
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nieuwegein, Netherlands
View Trial Details

Related conditions